Abstract
To investigate the association between Korean red ginseng (KRG) intake in HIV-1 infected patients and the occurrence of grossly deleted nef genes (gΔnef), we characterized nef genes in 10 long-term slow progressors (LTSP) infected with HIV-1 subtype B and 34 control patients. LTSP was defined by the annual decrease in CD4 T cells being less than 20/μl over 10 years in the absence of antiretroviral therapy. They were treated with KRG for a prolonged period. Nef genes were amplified from peripheral blood mononuclear cells (PBMC) using nested PCR and the products were sequenced directly. It was observed that the patients CD4 T cell counts decreased from 444 ± 207/μl to 294 ± 177/μl over 136 ± 23 months of KRG intake. This corresponds to an annual decrease in the level of CD4 T cells of 13.3/μl. A total of 479 nef genes were amplified from 137 PBMC samples. Nine out of the 10 patients, 47 (34.3 %) out of the 137 samples, and 90 out of the 479 genes revealed gΔnef. The deletion extended outside the nef gene in 25 gΔnef obtained from 6 patients. The proportion of samples with gΔnef (34.3 %) was significantly higher than 4.8 % in control patients (P < 0.001). In addition, it significantly increased as the duration of KRG intake prolongs (P < 0.01). These data suggest that the occurrence of g nef might be associated with long-term intake of KRG.
Keywords: Korean red ginseng, HIV-1 subtype B, long-term slow progressor, Grossly deleted nef
Current HIV Research
Title: High Frequency of Grossly Deleted nef Genes in HIV-1 Infected Long-Term Slow Progressors Treated with Korean Red Ginseng
Volume: 4 Issue: 4
Author(s): Heungsup Sung, Hee J. Lee, Ji Y. Lim, You S. Jung, Sun K. Oh, Young K. Cho, Ji Y. Lim, You S. Jung, Sun K. Oh and Hee J. Lee
Affiliation:
Keywords: Korean red ginseng, HIV-1 subtype B, long-term slow progressor, Grossly deleted nef
Abstract: To investigate the association between Korean red ginseng (KRG) intake in HIV-1 infected patients and the occurrence of grossly deleted nef genes (gΔnef), we characterized nef genes in 10 long-term slow progressors (LTSP) infected with HIV-1 subtype B and 34 control patients. LTSP was defined by the annual decrease in CD4 T cells being less than 20/μl over 10 years in the absence of antiretroviral therapy. They were treated with KRG for a prolonged period. Nef genes were amplified from peripheral blood mononuclear cells (PBMC) using nested PCR and the products were sequenced directly. It was observed that the patients CD4 T cell counts decreased from 444 ± 207/μl to 294 ± 177/μl over 136 ± 23 months of KRG intake. This corresponds to an annual decrease in the level of CD4 T cells of 13.3/μl. A total of 479 nef genes were amplified from 137 PBMC samples. Nine out of the 10 patients, 47 (34.3 %) out of the 137 samples, and 90 out of the 479 genes revealed gΔnef. The deletion extended outside the nef gene in 25 gΔnef obtained from 6 patients. The proportion of samples with gΔnef (34.3 %) was significantly higher than 4.8 % in control patients (P < 0.001). In addition, it significantly increased as the duration of KRG intake prolongs (P < 0.01). These data suggest that the occurrence of g nef might be associated with long-term intake of KRG.
Export Options
About this article
Cite this article as:
Sung Heungsup, Lee J. Hee, Lim Y. Ji, Jung S. You, Oh K. Sun, K. Cho Young, Y. Lim Ji, S. Jung You, K. Oh Sun and J. Lee Hee, High Frequency of Grossly Deleted nef Genes in HIV-1 Infected Long-Term Slow Progressors Treated with Korean Red Ginseng, Current HIV Research 2006; 4 (4) . https://dx.doi.org/10.2174/157016206778560072
DOI https://dx.doi.org/10.2174/157016206778560072 |
Print ISSN 1570-162X |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4251 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Perspectives of Activated Protein C in the Vasculature: Update on Proposed Roles of the Protein C Pathway
Current Genomics Preface
Current Pharmaceutical Design Network Pharmacology Analysis on Zhichan Powder in the Treatment of Parkinson's Disease
Combinatorial Chemistry & High Throughput Screening Hypoxia Inducible Factor-1 in Cancer Immune Suppression
Current Immunology Reviews (Discontinued) Immunosuppressive Drugs in HIV Disease
Current Topics in Medicinal Chemistry pH Effects in Micellar Liquid Chromatographic Analysis for Determining Partition Coefficients for a Series of Pharmaceutically Related Compounds
Current Pharmaceutical Analysis Chelating Agents for Metal Intoxication
Current Medicinal Chemistry Protein kinases and the Hypoxia-Inducible Factor-1, two switches in angiogenesis
Current Pharmaceutical Design The Mutual Interaction Between Sleep and Epilepsy on the Neurobiological Basis and Therapy
Current Neuropharmacology Current Advances in Gene Therapy for the Treatment of Genodermatoses
Current Gene Therapy HIF-1 Inhibitors for Cancer Therapy: From Gene Expression to Drug Discovery
Current Pharmaceutical Design Cefpodoxime Proxetil-Related Hemolysis and Acute Interstitial Nephritis
Current Drug Safety Delayed Multiple Non-ischemic Cerebral Enhanced Lesions After Endovascular Therapy For Left Internal Carotid Aneurysm: A Case Report
Current Medical Imaging Potential Linkage Between Cerebrovascular Diseases and Metabolic Syndrome
Current Drug Metabolism Neurokinin Receptors as Potential Targets in Breast Cancer Treatment
Current Drug Discovery Technologies Gene Therapy Strategies for Glaucomatous Neurodegeneration
Current Gene Therapy Ion Transport Across the Gallbladder Epithelium
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Heat Shock Protein Gp96 as Potential Regulator of Morphostasis after Partial Hepatectomy in Mice
Current Aging Science Immunomodulatory Properties of ES-62, a Phosphorylcholine - Containing Glycoprotein Secreted by Acanthocheilonema viteae
Endocrine, Metabolic & Immune Disorders - Drug Targets Griseofulvin and/or Terbinafine Induced Toxic Epidermal Necrolysis in an Adult Female Patient - A Case Report
Current Drug Safety